Kova combines clinician-reviewed GLP-1 care with medication delivery and a companion app. Its homepage publishes introductory monthly prices and longer-plan equivalents. The main buying question is which agreement accompanies the payment option: a month-to-month plan, a fixed commitment billed monthly, or a prepaid term with possible outside financing.

Those arrangements have different cancellation calculations in the October 2 terms. A monthly payment does not necessarily mean a month-to-month obligation, and a refund for unused prepaid months depends on prescription and shipment status. This review explains the public rules without assuming that every pricing card maps to the same type of agreement.

Offer highlights

  • Homepage publishes full totals beside longer-plan equivalents
  • Terms distinguish monthly commitments from prepaid terms
  • Medical-cancellation provisions are described separately

Ask before paying

  • Which plan category am I buying?
  • What standard rate, exit rate and cap apply?
  • How many months count as shipped in each delivery?

Prices and the amount behind each equivalent

For semaglutide, the homepage FAQ lists $249 for the first month of a one-month plan, renewing at $299. Longer offers are $179 per month or $537 upfront for three months; $149 per month or $894 upfront for six months; and $129 per month or $1,548 upfront for twelve months.

For tirzepatide, the one-month plan begins at $299 and renews at $399. The longer offers are $249 per month or $747 upfront for three months; $229 per month or $1,374 upfront for six months; and $199 per month or $2,388 upfront for twelve months. These totals are published by Kova, rather than inferred from a single starting-price card.

The company says medication, clinician consultations, delivery, ongoing care support and access to its app are included. We did not complete checkout or verify a patient-specific prescription, financing offer, tax amount or renewal term. The plan terms presented at enrollment take priority over inconsistent economic wording in the general terms.

Initial approval and later billing have different rules

The terms identify LifeTech Apps Inc., a Delaware company, as the platform operator. Independent providers make prescribing decisions and licensed pharmacies dispense medicines. The actual medical practice, clinician and pharmacy for a particular reader were not verified.

Kova may place a temporary authorization hold at initial enrollment. Its terms say it will capture the initial plan charge only after clinical eligibility is established and an initial prescription is issued; otherwise the hold is released or voided. That is the written rule, not a payment-flow result tested by this publication.

After enrollment, a recurring charge may occur before a refill review or prescription renewal is complete. Failing to request a refill, deleting the app or deciding not to use the service does not itself stop billing. A billing period can begin even when a shipment has not occurred, so record the renewal date and the steps required to cancel.

A fixed commitment billed monthly can be repriced

Section 10.5 covers plans explicitly sold as Fixed-Term Commitment Plans. Fees are due monthly in advance; the entire term is not immediately due, and the terms say future monthly fees are not accelerated into a full-term balance on cancellation.

For voluntary early cancellation, completed program months may be repriced at the standard rate disclosed at enrollment. The adjustment is the standard rate multiplied by completed months, minus fees already paid or credited for those months. A month counts as completed once it begins, rather than after every day has elapsed.

The adjustment is capped at the smaller of the enrollment-disclosed maximum or fees that would otherwise become payable for the remaining term. It must be disclosed before charging. The selected standard rate and cap were not verified, so the advertised starting price alone cannot calculate an individual exit cost.

If a provider determines that continued treatment is not clinically appropriate, the terms allow cancellation without that adjustment. Future fees stop when cancellation becomes effective, while a month already begun and products already dispensed or shipped generally remain nonrefundable. Turning off renewal prevents the next term; it does not by itself end the current commitment.

A prepaid term uses shipped months instead

Section 10.6 defines a Multi-Month Plan as one prepaid purchase for a fixed term and total price. A monthly equivalent or third-party financing does not turn it into a month-to-month plan. A voluntary cancellation can stop future shipments where operationally possible.

Its refund formula subtracts the disclosed early-cancellation rate multiplied by shipped months from the prepaid price, with the retained amount capped at the purchase price. A month becomes a shipped month when its medication has been dispensed or shipped. If one shipment covers several months, each covered month counts. Calendar months left on the plan are therefore not necessarily refundable months.

Before the first shipped month, the terms promise a full refund if no initial prescription is issued, a provider finds treatment inappropriate, or the plan cannot lawfully or operationally be supplied. If a provider later determines treatment is inappropriate, the early-cancellation rate does not apply: unshipped months are refunded using the original prepaid price divided by the plan’s term.

Financing is a separate agreement with an outside lender. Canceling Kova does not itself cancel that agreement. An approved refund normally runs through the original transaction, with the lender deciding how it affects the remaining balance and scheduled payments. Obtain both sets of terms before treating a financed purchase as flexible monthly care.

What the app and clinical claims establish

The site describes reminders, progress tracking, guidance and check-ins. Those features may help organize a care plan, but this review did not test the app, clinician response time, refill reliability or a patient’s treatment outcome. Delivery estimates and messaging access are not measured response guarantees.

Kova’s FAQ discusses averages from studies of branded semaglutide and tirzepatide and notes that compounded results may differ. Those trial averages are not a Kova patient cohort. FDA does not approve compounded GLP-1 drugs or perform the same premarket review they receive as approved products. Ask the prescriber why compounding is appropriate for the individual need and identify the actual formulation and pharmacy.

The documents to keep before starting

Save the selected plan’s price, term, next charge, renewal setting and cancellation method. For a monthly commitment, also keep the standard rate and maximum adjustment. For a prepaid term, keep the early-cancellation rate and how many months each shipment covers. Those details determine the practical effect of the published formulas.

The cost guide helps compare the resulting obligations. GoodGirlRx also advertises prepaid terms, while LongevityRx has a different notice-period conflict. These are comparisons of disclosed commercial information, not clinical rankings or guarantees of a refund.

Put the offer in context

Read the GLP-1 program comparison and complete cost guide to compare membership, medication, and recurring charges. The branded and compounded treatment guide explains the product distinctions.

Our CoreAge Rx review describes its advertised medicine-inclusive monthly offer and refund deadlines.

Sources & offer details

New provider sources checked October 15, 2026. Earlier guide material retains its original source history. Provider statements describe the advertised offer; they do not independently establish treatment outcomes.

  1. Kova: Pricing, program and FAQ ↗
  2. Kova: October 2 terms, including plan cancellation ↗
  3. FDA: Concerns with unapproved GLP-1 drugs ↗